CryoCor starts cardiac cryoablation trial:
This article was originally published in Clinica
Executive Summary
CryoCor has begun a clinical trial in Europe and Hong Kong to evaluate its CryoCor cardiac cryoablation system as a treatment for patients with rapid and irregular heartbeats, including atrial fibrillation. After completing the trial, the San Diego, California company plans to CE-mark the device for sale in Europe and submit a request to the FDA for permission to conduct a similar trial in the US.